 |
Nutritional Therapy for Primary Peritoneal Cancer: A Case Study - References
Articles |
References
Back to the Table of Contents
1. Agrawal, A.: Engineered dendritic cells enhance T-cell response. http://www.oncolink.com
2. Alberts B, Bray D, Lewis J, et al.: The Molecular Biology of the Cell, Third Edition (Garland Publishing, New York, NY), 1294 pages, 1994.
3. Attur MG, Patel R, DiCesare PE, Steiner GC, Abramson SB, Amin AR. Regulation of nitric oxide production by salicylates and tenidap in human OA-affected cartilage, rat chondrosarcomas and bovine chondrocytes. Osteoarthritis Cartilage. 1998 Jul;6(4):269-77.
4. Aust AE, Eveleigh JF: Mechanisms of DNA oxidation. Proceedings of the Society for Experimental Biology and Medicine 222(3): 246-252, 1999.
5. Barbieri B, Lund B, Lundstrom B, et al.: Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers -- a single blind placebo-controlled and randomized clinical study. BioFactors 9(2-4): 351-357, 1999.
6. Berberi P, Thibodeau A, Germain L, et al.: Antiangiogenic effects of the oral administration of liquid cartilage extract in humans. Journal of Surgical Research 87: 108-113, 1999.
7. Beyer RE, Nordenbrand K, Ernster L: The role of coenzyme Q as a mitochondrial antioxidant: a short review. In: Folkers K, Yamamura Y: Biomedical and Clinical Aspects of Coenzyme Q, Volume 5. Amsterdam, The Netherlands: Elsevier Science Publishers B.V. (Biomedical Division), 1986: pp 17-24.
8. Burcham PC: Internal hazards: baseline DNA damage by endogenous products of normal metabolism. Mutation Research 443(1-2): 11-36, 1999.
9.Cassileth BR: Shark and bovine cartilage therapies. In: The Alternative Medicine Handbook (WW Norton & Company, New York, NY), pp. 197- 200, 1998.
10.National Center for Complementary and Alternative Medicine (NCCAM) http://nccam.nih.gov/
11. National Center for Complementary and Alternative Medicine (NCCAM) http://nccam.nih.gov/
12. Complementary treatments highlighted at recent meeting. Oncology (Huntington NY) 13(2): 166, 1999.
13. Crane FL, Sun IL, Sun EE: The essential functions of coenzyme Q. Clinical Investigator 71(suppl 8): S55-S59, 1993.
14. Cremer MA, Rosloniec EF, Kang AH: The cartilage collagens: A review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. Journal of Molecular Medicine 76: 275-288, 1998.
15. Dreher D, Junod AF: Role of oxygen free radicals in cancer development. European Journal of Cancer 32A(1): 30-38, 1996.
16.Durie BG, Soehnlen B, Prudden JF: Antitumor activity of bovine cartilage extract (Catrix-S) in the human tumor stem cell assay. Journal of Biological Response Modifiers 4(6): 590-595, 1985.
17. Editor's of Pharmacist's Letter/Prescriber's Letter: Coenzyme Q10. In: Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty, 1999: 241-242.
18. Ernster L, Forsmark-Andree P: Ubiquinol: an endogenous antioxidant in aerobic organisms. Clinical Investigator 71(suppl 8): S60-S65, 1993.
19. Folkers K: Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy. Biochemical and Biophysical Research Communications 224(2): 358-361, 1996.
20. Folkers K, Brown R, Judy WV, et al.: Survival of cancer patients on therapy with coenzyme Q10. Biochemical and Biophysical Research Communications 192(1): 241-245, 1993.
21. Folkers K, Osterborg A, Nylander M, et al.: Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochemical and Biophysical Research Communications 234(2): 296-299, 1997.
22. Fujisawa N, Sato NL, Motoyama TI. Inhibitory effects of transforming growth factor-beta1 pretreatment on experimental pulmonary metastasis of MCS-1 Chinese hamster mesenchymal chondrosarcoma cells. Tohoku J Exp Med. 1999 Mar;187(3):203-13.
23. Gordon MH: Dietary antioxidants in disease prevention. Natural Product Reports 13(4): 265-273, 1996.
24. Haas TL, Madri JA: Extracellular matrix-driven metalloproteinase production in endothelial cells: Implications for angiogenesis. Trends in Cardiovascular Medicine 9(3/4): 70-77, 1999.
25. Halliwell B: Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutation Research 443(1-2): 37-52, 1999.
26. Hiraki Y, Inoue H, Iyama K-I, et al.: Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Journal of Biological Chemistry 272(51): 32419-32426, 1997.
27. Hodges S, Hertz, Lockwood K, et al.: CoQ10: could it have a role in cancer management? BioFactors 9(2-4): 365-370, 1999.
28. http://www.cancure.org/choiceoftherapy.htm
29. http://www.cancer.gov
30. http://www.canceroption.com/protocols/protocol.asp?id=12&name=Ovarian%20Cancer
31. http://www.canceroption.com/protocols/protocol.asp?topi_id=34&name=Ovarian%20Cancer&id=12#44
32. http://www.wheat-grass.com
33. Janusz MJ, Hare M, Durham SL, Potempa J, McGraw W, Pike R, Travis J, Shapiro SD. Cartilage proteoglycan degradation by a mouse transformed macrophage cell line is mediated by macrophage metalloelastase. Inflamm Res. 1999 May;48(5):280-8.
34. Jolliet P, Simon N, Barre J, et al.: Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences. International Journal of Clinical Pharmacology and Therapeutics 36(9): 506- 509, 1998.
35. Kaikkonen J, Nyyssonen K, Tuomainen TP, et al.: Determinants of plasma coenzyme Q10 in humans. Federation of European Biochemical Societies Letters 443(2): 163-166, 1999.
36. National Center for Complementary and Alternative Medicine (NCCAM) http://nccam.nih.gov/
37. Li C-Y, Shan S, Huang Q, et al.: Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. Journal of the National Cancer Institute 92(2): 143-147, 2000.
38. Liu N, Lapcevich RK, Underhill CB, Han Z, Gao F, Swartz G, Plum SM, Zhang L, Gree SJ. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth. Cancer Res. 2001 Feb 1;61(3):1022-8.
39. Lockwood K, Moesgaard S, Folkers K: Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and Biophysical Research Communications 199(3): 1504-1508, 1994.
40. Lockwood K, Moesgaard S, Hanioka T, et al.: Apparent partial remission of breast cancer in "high risk" patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Molecular Aspects of Medicine 15(suppl): S231-S240, 1994.
41. Lockwood K, Moesgaard S, Yamamoto T, et al.: Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications 212(1): 172-177, 1995.
42. Mano T, Iwase K, Hayashi R, et al.: Vitamin E and coenzyme Q concentrations in the thyroid tissues of patients with various thyroid disorders. American Journal of the Medical Sciences 315(4): 230-232, 1998.
43.Markman, M. et al.: Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage. Journal of Clinical Oncology, 19, 1001-1007, 2/15/2001
44. McCawley LJ, Matrisian LM: Matrix metalloproteinases: Multifunctional contributors to tumor progression. Molecular Medicine Today 6: 149-156, 2000.
45. McIntosh GH, Royle PJ, Pointing G. Wheat aleurone flour increases cecal beta-glucuronidase activity and butyrate concentration and reduces colon adenoma burden in azoxymethane-treated rats. J Nutr. 2001 Jan;131(1):127-31.
46. Murray JB, Allison K, Sudhalter J, et al.: Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor. Journal of Biological Chemistry 261(9): 4154-4159, 1986.
47. Ohba Y, Goto Y, Kimura Y, et al.: Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8. Biochimica et Biophysica Acta 1245: 1-8, 1995.
48. Overvad K, Diamant B, Holm L, et al.: Coenzyme Q10 in health and disease. European Journal of Clinical Nutrition 53(10): 764-770, 1999.
49. Pajari AM, Oikarinen S, Grasten S, Mutanen M. Diets enriched with cereal brans or inulin modulate protein kinase C activity and isozyme expression in rat colonic mucosa. Br J Nutr. 2000 Nov;84(5):635-43.
50. Palazzoni G, Pucello D, Littarru GP, et al.: Coenzyme Q10 and colorectal neoplasms in aged patients. Rays 22(suppl 1): 73-76, 1997.
51.Pauli BU, Memoli VA, Kuettner KE: Regulation of tumor invasion by cartilage-derived anti-invasion factor in vitro. Journal of the National Cancer Institute 67(1): 65-70, 1981.
52. Pepping J: Coenzyme Q. American Journal of Health-System Pharmacy 56: 519-521, 1999.
53. Picardo M, Grammatico P, Roccella F, et al.: Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. Journal of Investigative Dermatology 107(3): 322-326, 1996.
54. Piver, M. S., Eitabbakh, G.: Myths and facts about ovarian cancer, second edition. New York: PRR, Inc., 2000.
55. Portakal O, Ozkaya O, Inal ME, et al.: Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clinical Biochemistry 33(4): 279-284, 2000.
56. Prudden JF: The treatment of human cancer with agents prepared from bovine cartilage. Journal of Biological Response Modifiers 4: 551-584, 1985.
57. Puccio C, Mittelman A, Chun P, et al.: Treatment of metastatic renal cell carcinoma with Catrix. Proceedings of the American Society of Clinical Oncology 13: A769, 1994.
58. Quillin P. Midwestern Regional Medical Center: Phase II study of the safety and efficacy of bovine tracheal cartilage in the treatment of advanced or metastatic cancer (Summary last modified 09/1997), MRMC-CTCA-9506, clinical trial, closed, 03/05/1997.
59. Ren S, Lien EJ: Natural products and their derivatives as cancer chemopreventive agents. Progress in Drug Research 48: 147-171, 1997.
60. Romano CF, Lipton A, Harvey HA, et al.: A phase II study of Catrix-S in solid tumors. Journal of Biological Response Modifiers 4(6): 585-589, 1985.
61. Suzuki F: Cartilage-derived growth factor and antitumor factor: Past, present, and future studies. Biochemical and Biophysical Research Communications 259: 1-7, 1999.
62. Takigawa M, Pan H-O, Enomoto, et al.: A clonal human chondrosarcoma cell line produces an anti-angiogenic antitumor factor. Anticancer Research 10: 311-316, 1990.
63. Takigawa M, Shirai E, Enomoto M, et al.: A factor in conditioned medium of rabbit costal chondrocytes inhibits the proliferation of cultured endothelial cells and angiogenesis induced by B16 melanoma: its relation with cartilage-derived anti-tumor factor (CATF). Biochemistry International 14(2): 357-363, 1987.
64. Takigawa M, Shirai E, Enomoto M, et al.: Cartilage-derived anti-tumor factor (CATF) inhibits the proliferation of endothelial cells in culture. Cell Biology International Reports 9(7): 619-625, 1985.
65. Terry P, Lagergren J, Ye W, Wolk A, Nyren O. Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology. 2001 Feb;120(2):387-91.
66. Understanding your Taxol therapy. Princeton, NJ: Bristol-Myers Squibb Oncology, 1999.
67. Warshal, D.: Summary: Evaluation of bovine trachael cartilage in recurrent ovarian and primary peritoneal carcinoma. http://www.centerwatch.com/studies/stu13021.htm
68. Wojtowicz-Praga S: Clinical potential of matrix metalloproteinase inhibitors. Drugs R&D 1(2): 117-129, 1999.
70. Yamamoto Y, Yamashita S, Fujisawa A, et al.: Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochemical and Biophysical Research Communications 247(1): 166-170, 1998.
|
You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you. |
|
